BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33407903)

  • 1. The App
    Vandenabeele M; Veys L; Lemmens S; Hadoux X; Gelders G; Masin L; Serneels L; Theunis J; Saito T; Saido TC; Jayapala M; De Boever P; De Strooper B; Stalmans I; van Wijngaarden P; Moons L; De Groef L
    Acta Neuropathol Commun; 2021 Jan; 9(1):6. PubMed ID: 33407903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App
    Nuñez-Diaz C; Andersson E; Schultz N; Pocevičiūtė D; Hansson O; ; Nilsson KPR; Wennström M
    Alzheimers Res Ther; 2024 Jan; 16(1):4. PubMed ID: 38167557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia/macrophage phenotype in amyloid precursor protein transgenic mice.
    Maier M; Peng Y; Jiang L; Seabrook TJ; Carroll MC; Lemere CA
    J Neurosci; 2008 Jun; 28(25):6333-41. PubMed ID: 18562603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations into Retinal Pathology in the Early Stages of a Mouse Model of Alzheimer's Disease.
    Chidlow G; Wood JP; Manavis J; Finnie J; Casson RJ
    J Alzheimers Dis; 2017; 56(2):655-675. PubMed ID: 28035930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in open field activity in the absence of memory deficits in the App
    Whyte LS; Hemsley KM; Lau AA; Hassiotis S; Saito T; Saido TC; Hopwood JJ; Sargeant TJ
    Behav Brain Res; 2018 Jan; 336():177-181. PubMed ID: 28887197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presubiculum principal cells are preserved from degeneration in knock-in APP/TAU mouse models of Alzheimer's disease.
    Islam A; Saito T; Saido T; Ali AB
    Semin Cell Dev Biol; 2023 Apr; 139():55-72. PubMed ID: 35292192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice.
    Peters DG; Pollack AN; Cheng KC; Sun D; Saido T; Haaf MP; Yang QX; Connor JR; Meadowcroft MD
    Metallomics; 2018 Mar; 10(3):426-443. PubMed ID: 29424844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.
    Yamamoto M; Kiyota T; Horiba M; Buescher JL; Walsh SM; Gendelman HE; Ikezu T
    Am J Pathol; 2007 Feb; 170(2):680-92. PubMed ID: 17255335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid β accumulation and inner retinal degenerative changes in Alzheimer's disease transgenic mouse.
    Gupta VK; Chitranshi N; Gupta VB; Golzan M; Dheer Y; Wall RV; Georgevsky D; King AE; Vickers JC; Chung R; Graham S
    Neurosci Lett; 2016 Jun; 623():52-6. PubMed ID: 27133194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease in the retina: imaging retinal aβ plaques for early diagnosis and therapy assessment.
    Koronyo Y; Salumbides BC; Black KL; Koronyo-Hamaoui M
    Neurodegener Dis; 2012; 10(1-4):285-93. PubMed ID: 22343730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.
    Perez SE; Lumayag S; Kovacs B; Mufson EJ; Xu S
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):793-800. PubMed ID: 18791173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. App
    Hamaguchi T; Tsutsui-Kimura I; Mimura M; Saito T; Saido TC; Tanaka KF
    Neurochem Int; 2019 Oct; 129():104470. PubMed ID: 31102607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-Dependent Effects of Intestinal Microbiome Manipulation in a Mouse Model of Alzheimer's Disease.
    Kaur H; Nookala S; Singh S; Mukundan S; Nagamoto-Combs K; Combs CK
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-Dependent Sex Differences in Perineuronal Nets in an
    Rahmani R; Rambarack N; Singh J; Constanti A; Ali AB
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.
    Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T
    Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyroglutamate Abeta pathology in APP/PS1KI mice, sporadic and familial Alzheimer's disease cases.
    Wirths O; Bethge T; Marcello A; Harmeier A; Jawhar S; Lucassen PJ; Multhaup G; Brody DL; Esparza T; Ingelsson M; Kalimo H; Lannfelt L; Bayer TA
    J Neural Transm (Vienna); 2010 Jan; 117(1):85-96. PubMed ID: 19823761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.
    Benitez DP; Jiang S; Wood J; Wang R; Hall CM; Peerboom C; Wong N; Stringer KM; Vitanova KS; Smith VC; Joshi D; Saito T; Saido TC; Hardy J; Hanrieder J; De Strooper B; Salih DA; Tripathi T; Edwards FA; Cummings DM
    Mol Neurodegener; 2021 Jul; 16(1):47. PubMed ID: 34266459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.